698 related articles for article (PubMed ID: 20579539)
1. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
[TBL] [Abstract][Full Text] [Related]
2. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Wei J; Mehta PK; Johnson BD; Samuels B; Kar S; Anderson RD; Azarbal B; Petersen J; Sharaf B; Handberg E; Shufelt C; Kothawade K; Sopko G; Lerman A; Shaw L; Kelsey SF; Pepine CJ; Merz CN
JACC Cardiovasc Interv; 2012 Jun; 5(6):646-53. PubMed ID: 22721660
[TBL] [Abstract][Full Text] [Related]
3. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.
Reis SE; Holubkov R; Lee JS; Sharaf B; Reichek N; Rogers WJ; Walsh EG; Fuisz AR; Kerensky R; Detre KM; Sopko G; Pepine CJ
J Am Coll Cardiol; 1999 May; 33(6):1469-75. PubMed ID: 10334410
[TBL] [Abstract][Full Text] [Related]
4. Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.
AlBadri A; Bairey Merz CN; Johnson BD; Wei J; Mehta PK; Cook-Wiens G; Reis SE; Kelsey SF; Bittner V; Sopko G; Shaw LJ; Pepine CJ; Ahmed B
J Am Coll Cardiol; 2019 Feb; 73(6):684-693. PubMed ID: 30765035
[TBL] [Abstract][Full Text] [Related]
5. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.
Rutledge T; Reis SE; Olson MB; Owens J; Kelsey SF; Pepine CJ; Mankad S; Rogers WJ; Merz CN; Sopko G; Cornell CE; Sharaf B; Matthews KA; Vaccarino V
Arch Gen Psychiatry; 2006 Aug; 63(8):874-80. PubMed ID: 16894063
[TBL] [Abstract][Full Text] [Related]
6. Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study.
Denardo SJ; Wen X; Handberg EM; Bairey Merz CN; Sopko GS; Cooper-Dehoff RM; Pepine CJ
Clin Cardiol; 2011 Aug; 34(8):483-7. PubMed ID: 21780138
[TBL] [Abstract][Full Text] [Related]
7. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Implications of Coronary Flow Capacity: A Comprehensive Cross-Modality Physiological Concept in Ischemic Heart Disease.
van de Hoef TP; Echavarría-Pinto M; van Lavieren MA; Meuwissen M; Serruys PW; Tijssen JG; Pocock SJ; Escaned J; Piek JJ
JACC Cardiovasc Interv; 2015 Nov; 8(13):1670-80. PubMed ID: 26585617
[TBL] [Abstract][Full Text] [Related]
9. Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE).
Wessel TR; Arant CB; McGorray SP; Sharaf BL; Reis SE; Kerensky RA; von Mering GO; Smith KM; Pauly DF; Handberg EM; Mankad S; Olson MB; Johnson BD; Merz CN; Sopko G; Pepine CJ;
Clin Cardiol; 2007 Feb; 30(2):69-74. PubMed ID: 17326061
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Doyle M; Weinberg N; Pohost GM; Bairey Merz CN; Shaw LJ; Sopko G; Fuisz A; Rogers WJ; Walsh EG; Johnson BD; Sharaf BL; Pepine CJ; Mankad S; Reis SE; Vido DA; Rayarao G; Bittner V; Tauxe L; Olson MB; Kelsey SF; Biederman RW
JACC Cardiovasc Imaging; 2010 Oct; 3(10):1030-6. PubMed ID: 20947048
[TBL] [Abstract][Full Text] [Related]
11. Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Nichols WW; Denardo SJ; Davidson JB; Huo T; Bairey Merz CN; Pepine CJ
Am Heart J; 2015 Dec; 170(6):1243-54. PubMed ID: 26678647
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
Anderson RD; Petersen JW; Mehta PK; Wei J; Johnson BD; Handberg EM; Kar S; Samuels B; Azarbal B; Kothawade K; Kelsey SF; Sharaf B; Shaw LJ; Sopko G; Bairey Merz CN; Pepine CJ
J Interv Cardiol; 2019; 2019():7169275. PubMed ID: 31772544
[TBL] [Abstract][Full Text] [Related]
13. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation.
Thomson LE; Wei J; Agarwal M; Haft-Baradaran A; Shufelt C; Mehta PK; Gill EB; Johnson BD; Kenkre T; Handberg EM; Li D; Sharif B; Berman DS; Petersen JW; Pepine CJ; Bairey Merz CN
Circ Cardiovasc Imaging; 2015 Apr; 8(4):. PubMed ID: 25801710
[TBL] [Abstract][Full Text] [Related]
14. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
Wessel TR; Arant CB; Olson MB; Johnson BD; Reis SE; Sharaf BL; Shaw LJ; Handberg E; Sopko G; Kelsey SF; Pepine CJ; Merz NB
JAMA; 2004 Sep; 292(10):1179-87. PubMed ID: 15353530
[TBL] [Abstract][Full Text] [Related]
15. Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
Park K; Quesada O; Cook-Wiens G; Wei J; Minissian M; Handberg EM; Merz NB; Pepine CJ
J Womens Health (Larchmt); 2020 Apr; 29(4):487-492. PubMed ID: 31859580
[No Abstract] [Full Text] [Related]
16. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).
Pauly DF; Johnson BD; Anderson RD; Handberg EM; Smith KM; Cooper-DeHoff RM; Sopko G; Sharaf BM; Kelsey SF; Merz CN; Pepine CJ
Am Heart J; 2011 Oct; 162(4):678-84. PubMed ID: 21982660
[TBL] [Abstract][Full Text] [Related]
17. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
von Mering GO; Arant CB; Wessel TR; McGorray SP; Bairey Merz CN; Sharaf BL; Smith KM; Olson MB; Johnson BD; Sopko G; Handberg E; Pepine CJ; Kerensky RA;
Circulation; 2004 Feb; 109(6):722-5. PubMed ID: 14970106
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice.
Marroquin OC; Holubkov R; Edmundowicz D; Rickens C; Pohost G; Buchthal S; Pepine CJ; Sopko G; Sembrat RC; Meltzer CC; Reis SE
Am Heart J; 2003 Apr; 145(4):628-35. PubMed ID: 12679758
[TBL] [Abstract][Full Text] [Related]
19. Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).
Mekonnen G; Hayek SS; Mehta PK; Li Q; Mahar E; Mou L; Kenkre TS; Petersen JW; Azarbal B; Samuels B; Anderson RD; Sedlak T; Zaya M; Agarwal M; Haftbaradaran A; Minissian M; Handberg E; Pepine CJ; Cogle CR; Bairey Merz CN; Waller EK; Quyyumi AA
Atherosclerosis; 2016 Oct; 253():111-117. PubMed ID: 27596135
[TBL] [Abstract][Full Text] [Related]
20. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Johnson BD; Shaw LJ; Buchthal SD; Bairey Merz CN; Kim HW; Scott KN; Doyle M; Olson MB; Pepine CJ; den Hollander J; Sharaf B; Rogers WJ; Mankad S; Forder JR; Kelsey SF; Pohost GM;
Circulation; 2004 Jun; 109(24):2993-9. PubMed ID: 15197152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
